ConductScience.org, home

Paper8739655

The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.

Harvey HA and 1 other. Support Care Cancer, 1996. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience. Papers, record 8739655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8739655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.
PubMed
Journal
Support Care Cancer
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.42
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harvey HAH A
2Lipton AA

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Bone NeoplasmsMajor topic
Clinical Trials as TopicMajor topic
DiphosphonatesMajor topic
Bone Resorption
Breast Neoplasms
Clinical Trials, Phase I as Topic
Clinical Trials, Phase III as Topic
Female
Fractures, Spontaneous
Humans
Hypercalcemia
Injections, Intravenous
Male
Multiple Myeloma
Osteoclasts
Pain
Palliative Care
Pamidronate
Placebos
Prostatic Neoplasms
Randomized Controlled Trials as Topic
Spinal Cord Compression
United States

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11825515Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton.Oncology1991https://conductscience.org/library/papers/1825515PubMed
27525038Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.Cancer1994https://conductscience.org/library/papers/7525038PubMed
37466408Treatment of bone metastases.Semin Oncol1980https://conductscience.org/library/papers/7466408PubMed
48431928Osteoclast inhibition for the treatment of bone metastases.Cancer Treat Rev1993https://conductscience.org/library/papers/8431928PubMed
51525054Modulation of tumour-induced bone resorption by bisphosphonates.J Steroid Biochem Mol Biol1992https://conductscience.org/library/papers/1525054PubMed
61826438Treatment of bone metastases from breast cancer and myeloma with pamidronate.Eur J Cancer1991https://conductscience.org/library/papers/1826438PubMed
78242577New bisphosphonates in the treatment of bone metastases.Cancer1993https://conductscience.org/library/papers/8242577PubMed
86692261Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy.Cancer1984https://conductscience.org/library/papers/6692261PubMed
93514130Surgical stabilization of pathological neoplastic fractures.Curr Probl Cancer1986https://conductscience.org/library/papers/3514130PubMed
107680374Palliative pamidronate treatment in patients with bone metastases from breast cancer.J Clin Oncol1993https://conductscience.org/library/papers/7680374PubMed
117532993Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?Ann Oncol1994https://conductscience.org/library/papers/7532993PubMed
128471660Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.Ann Hematol1993https://conductscience.org/library/papers/8471660PubMed
137532991Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer.Ann Oncol1994https://conductscience.org/library/papers/7532991PubMed
148418243Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.J Clin Oncol1993https://conductscience.org/library/papers/8418243PubMed
157873461Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.Ann Oncol1994https://conductscience.org/library/papers/7873461PubMed
167105580Mechanisms of lytic and blastic metastatic disease of bone.Clin Orthop Relat Res1982https://conductscience.org/library/papers/7105580PubMed
178053405Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound.J Bone Miner Res1994https://conductscience.org/library/papers/8053405PubMed
187873458The role of pamidronate.Ann Oncol1994https://conductscience.org/library/papers/7873458PubMed
197987173Therapeutic use of bisphosphonates in oncology.BMJ1994https://conductscience.org/library/papers/7987173PubMed
208150777Bisphosphonates in breast cancer patients with skeletal metastases.Hematol Oncol Clin North Am1994https://conductscience.org/library/papers/8150777PubMed

See all 27 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
12496987Ibandronate in the treatment of prostate cancer associated painful osseous metastases.Prostate Cancer Prostatic Dis2002https://conductscience.org/library/papers/12496987PubMed
12076438Bisphosphonates for the relief of pain secondary to bone metastases.Cochrane Database Syst Rev2002https://conductscience.org/library/papers/12076438PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8739655

GET https://conductscience.org/api/papers/v1/8739655/references?page=2